The biologic effects of the loss of BRCA1 gene function caused by promoter hypermethylation and by coding-region mutations in breast and ovarian cancer produce similar microarray patterns of reduced gene expression (Hedenfalk et al, 2001). This evidence concerns the gene BRCA1 and ovarian carcinoma.